CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 77,344	$ 81,808
Restricted cash	1,000	1,549
Patient accounts receivable	275,632	255,145
Prepaid expenses	15,449	10,217
Other current assets	11,025	13,265
Total current assets	380,450	361,984
Property and equipment, net of accumulated depreciation of $97,698 and $95,024	21,679	23,719
Operating lease right of use assets	94,620	93,440
Goodwill	933,207	932,685
Intangible assets, net of accumulated amortization of $12,738 and $22,973	69,764	74,183
Deferred income taxes	40,576	47,987
Other assets	32,913	33,200
Total assets	1,573,209	1,567,198
Current liabilities:
Accounts payable	38,865	42,674
Payroll and employee benefits	150,887	146,929
Accrued expenses	170,954	166,192
Provider relief fund advance	55,000	60,000
Current portion of long-term obligations	10,329	10,496
Current portion of operating lease liabilities	30,047	30,046
Total current liabilities	456,082	456,337
Long-term obligations, less current portion	231,380	204,511
Operating lease liabilities, less current portion	63,359	61,987
Other long-term obligations	32,814	33,622
Total liabilities	783,635	756,457
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,538,837 and 37,470,212 shares issued; and 32,567,712 and 32,814,278 shares outstanding	38	38
Additional paid-in capital	707,006	698,287
Treasury stock, at cost 4,971,125 and 4,655,934 shares of common stock	(398,752)	(319,092)
Retained earnings	479,861	429,991
Total Amedisys, Inc. stockholders’ equity	788,153	809,224
Noncontrolling interests	1,421	1,517
Total equity	789,574	810,741
Total liabilities and equity	$ 1,573,209	$ 1,567,198